MicroRNA Regulation in Systemic Lupus Erythematosus Pathogenesis

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are key regulators of gene expression, influencing immune cell differentiation and function.
• Dysregulated miRNA networks are implicated in the pathogenesis of autoimmune diseases, including systemic lupus erythematosus (SLE).

Purpose of the Study:

• To review the role of microRNAs in immune cell regulation and their connection to autoimmune diseases, particularly SLE.
• To discuss the impact of aberrant miRNA expression on immune cell function and disease mechanisms in SLE.
• To explore the diagnostic and therapeutic potential of miRNAs in SLE.

Main Methods:

• Literature review of studies investigating miRNA involvement in autoimmunity and SLE.
• Analysis of miRNA profiling data comparing SLE patients and healthy controls.
• Discussion of functional outcomes associated with dysregulated miRNAs in SLE.

Main Results:

• Interruption of miRNA biogenesis and processing enzymes leads to abnormal immune cell development and function in autoimmune conditions.
• Distinct groups of miRNAs show aberrant expression in SLE, causing perturbed type I interferon signaling, DNA hypomethylation, and immune cell hyperactivation.
• While individual miRNA patterns vary, overlapping functional consequences are observed in SLE patients.

Conclusions:

• MicroRNA dysregulation significantly contributes to the pathogenesis of systemic lupus erythematosus by affecting immune cell function and signaling.
• Despite challenges in identifying consistent miRNA biomarkers, their role in SLE pathogenesis is evident.
• Advances in sequencing, bioinformatics, and functional models offer future potential for miRNA-based diagnostics and therapeutics in SLE.